Itacitinib monotherapy for GVHD, the role of ERG in EVI1-driven AML, and germline DDX41 mutations in myeloid neoplasms
Blood Podcast
00:00
Introduction
Learn how ERG was discovered to be a key transcriptional target in EVI-1-driven AML. define a unique subtype of myeloid neoplasms characterized by germline DDX-41 mutations. Discuss the safety and efficacy of idicitinib monotherapy in low-risk acute GVHD.
Transcript
Play full episode
